281-891-3003
522 Timberdale Ln, Houston, TX for Sale
Office - FOR SALE
1/2
null | Request Cap Rate

NEW


522 Timberdale Ln
Houston, TX 77090
Cypress Station


OVERVIEW

Capital Heights Properties is pleased to present a two-building medical office campus located in Houston, Texas. The offering consists of approximately ±29,891 SF across two single-story medical office buildings situated on a ±2.9-acre site within an established medical and commercial corridor. The campus benefits from strong accessibility, modern construction, and a configuration well suited for outpatient medical use. The first building, located at 522 Timberdale Lane, is a ±15,368 SF facility constructed in 2019 and is currently 100% occupied by Texas Oncology, providing immediate stabilized cash flow. The second building, located at 1250 Cypress Station, comprises approximately ±14,523 SF, was renovated in 2019, and is 46% occupied, offering near-term lease-up and value-add potential. The campus features flexible medical office layouts, modern building systems, and 178 on-site parking spaces, including 18 covered spaces, supporting patient and staff needs. Represented exclusively, this medical office campus offers a compelling opportunity to acquire a healthcare-focused asset combining income stability and future growth potential within the Houston market.

FOR SALE DETAILS

PRICE

Request Info for Price

CAP RATE

Request Cap Rate

% LEASED

-

TENANCY

-

SALE TYPE

Investment Or Owner User

BUILDING DETAILS

PROPERTY TYPE

Office

ADD'L SUBTYPES

Medical

TOTAL BUILDING SIZE

-

STORIES

1

BUILDING CLASS

B

YEAR BUILT

2020

SPRINKLERS

-

PARKING SPACES

-

LAND DETAILS

LAND ACRES

1.27 AC

LAND SF

55,164 SF

ZONING

-

APN/PARCEL ID

1082280000001

ASK ABOUT THIS PROPERTY

Maher MoukarimCapital Heights PropertiesMore Info
281-891-3003

By clicking the button, you agree to Showcase's Terms of Use and Privacy Notice.

Maher MoukarimCapital Heights PropertiesMore Info
281-891-3003

By clicking the button, you agree to Showcase's Terms of Use and Privacy Notice.